Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 6

Hemogram-derived inflammatory indices across electrophysiological subtypes of Guillain-Barré syndrome

Nur Türkmen(Ankara Bilkent City Hospital, Division of Clinical NEurophysiology)0000-0001-5863-7010
Yiğit Emre Dağdelen(Ankara Bilkent Şehir Hastanesi Nöroloji Kliniği)0009-0005-8280-9392
Hesna Bektaş(ANKARA YILDIRIM BEYAZIT UNIVERSITY, SCHOOL OF MEDICINE)0000-0003-3785-3341
Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings should be considered exploratory and require confirmation in larger prospective studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: This study aimed to evaluate the relationship between complete blood count-derived inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR), and electrophysiological subtypes and short-term clinical outcomes in patients with Guillain-Barré syndrome (GBS).
📊
Key Findings & Data:Methods: We retrospectively reviewed 50 adult patients with electrophysiologically confirmed GBS who were hospitalized in the neurology inpatient unit and/or intensive care unit between 2023 and 2025.
💡
Conclusion & Impact:These findings should be considered exploratory and require confirmation in larger prospective studies.
🔬Design:Review & Systematic Survey
📍Scope:2023 Verileri
⚙️Variables:Guillain-Barre Syndrome · biomarkers · blood cell count

Abstract

Aims: This study aimed to evaluate the relationship between complete blood count-derived inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR), and electrophysiological subtypes and short-term clinical outcomes in patients with Guillain-Barré syndrome (GBS). Methods: We retrospectively reviewed 50 adult patients with electrophysiologically confirmed GBS who were hospitalized in the neurology inpatient unit and/or intensive care unit between 2023 and 2025. Patients were classified as acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN), or acute motor-sensory axonal neuropathy (AMSAN). Miller Fisher syndrome and rare variants were excluded. NLR, MLR, and PLR were calculated from admission complete blood count parameters. These indices were compared across electrophysiological subtypes and according to symptom onset-to-admission interval, cranial involvement, and discharge outcome. GBS-DS and EGRIS scores were additionally evaluated according to treatment modality. Results: The mean age was 56.1±16.4 years, and 36 patients were male. Inflammatory indices differed significantly among electrophysiological subtypes, with the highest NLR, MLR, and PLR values observed in the AMSAN group (p=0.022, p=0.003, and p=0.038, respectively). Admission GBS-DS, discharge GBS-DS, and EGRIS scores differed significantly among treatment groups (p=0.003, p=0.024, and p=0.020, respectively); post hoc differences were observed between IVIG and combined IVIG plus plasmapheresis (PF) for GBS-DS scores and between IVIG and PF for EGRIS. Inflammatory indices were not significantly associated with cranial involvement or discharge outcome. Conclusion: Hemogram-derived inflammatory indices were associated with electrophysiological subtypes in GBS, with higher values observed in the AMSAN group. These findings should be considered exploratory and require confirmation in larger prospective studies.

🔖

Cite This Article

Türkmen, N., Dağdelen, Y. E., Bektaş, H. (2026). Hemogram-derived inflammatory indices across electrophysiological subtypes of Guillain-Barré syndrome. Anatolian Current Medical Journal, Volume: 8 Issue: 6. https://ajindex.com/articles/1667882

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (29)

  1. McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology. 2009;32(2): 150-163. doi:10.1159/000184748
  2. Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110-1115. doi:10.1212/wnl.51.4.1110
  3. Ginanneschi F, Giannini F, Sicurelli F, et al. Clinical features and outcome of the Guillain-Barre syndrome: a single-center 11-year experience. Front Neurol. 2022;13:856091. doi:10.3389/fneur.2022.856091
  4. Oh SJ. Nodal conduction block: a unifying concept. Muscle Nerve. 2021; 63(2):178-180. doi:10.1002/mus.27115
  5. Patel A, Panda S, Garg MK. Does serial nerve conduction studies with Rajabally criteria improve classification in Guillain-Barré syndrome? J Neurophysiol Neurol Disord. 2025;13:1-10. doi:10.17303/jnnd.2025.13.101
  6. Ozdemir HH. Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome. Arq Neuropsiquiatr. 2016;74(9):718-722. doi:10.1590/0004-282X20160132
  7. Rodríguez Y, Rojas M, Pacheco Y, et al. Guillain-Barré syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018;15(6):547-562. doi:10.1038/cmi.2017.142
  8. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469-482. doi:10.1038/nrneurol.2014.121
  9. Olsson A, Gustavsen S, Gisselø Lauridsen K, et al. Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: a systematic review. Acta Neurol Scand. 2021;143(6):577-586. doi:10.1111/ane.13401
  10. Sanchez-Boluarte SS, Aguirre-Quispe W, Tacunan-Cuellar J, Sanchez-Boluarte AN, Segura-Chavez D. Disability evaluation in patients with Guillain-Barré syndrome and SARS-CoV-2 infection. Front Neurol. 2023;14:1191520. doi:10.3389/fneur.2023.1191520
  11. Song S, Bai Y, Mu H, et al. An auxiliary diagnostic strategy for distinguishing Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: combining platelet-to-lymphocyte ratio and cerebrospinal fluid interleukin-8 levels. BMC Neurol. 2025;25(1): 314. doi:10.1186/s12883-025-04330-1
  12. Bano S, Nawaz A, Nasim A, Numan A, Zahid M. Correlation of cerebrospinal fluid total protein and serum neutrophil-to-lymphocyte ratio with clinical outcomes of Guillain-Barré syndrome variants. J Coll Physicians Surg Pak. 2024;34(2):187-192. doi:10.29271/jcpsp.2024.02.187
  13. van Doorn PA, Van den Bergh PYK, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain-Barré syndrome. Eur J Neurol. 2023;30(12): 3646-3674. doi:10.1111/ene.16073
  14. Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998;44(5):780-788. doi:10.1002/ana.410440512
  15. Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86(1):115-119. doi:10.1136/jnnp-2014-307815
  16. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005; 366(9497):1653-1666. doi:10.1016/S0140-6736(05)67665-9
  17. Kleyweg RP, van der Meché FGA, Schmitz PIM. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14(11):1103-1109. doi:10.1002/mus.880141111
  18. Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010;67(6):781-787. doi:10.1002/ana.21976
  19. Bedel C, Korkut M. The clinical significance of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and platelet lymphocyte ratio in patients with Guillain-Barré syndrome. Haydarpasa Numune Med J. 2021;61(3):341-345. doi:10.14744/hnhj.2019.38233
  20. Gümüşyayla Ş, Vural G. The predictive value of neutrophil-lymphocyte ratio in disability of Guillain-Barré syndrome. Med J Bakirkoy. 2019; 15(3):187-192. doi:10.4274/BTDMJB.galenos.2019.20171214071335
  21. Huang Y, Ying Z, Quan W, et al. The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barré syndrome. Int J Neurosci. 2018;128(8):729-735. doi:10.1080/00207454.2017.1418342
  22. Hashim NA, Mohamed WS, Emad EM. Neutrophil-lymphocyte ratio and response to plasmapheresis in Guillain-Barré syndrome: a prospective observational study. Egypt J Neurol Psychiatr Neurosurg. 2020;56(1):17. doi:10.1186/s41983-020-0154-z
  23. Ethemoğlu Ö, Çalık M. Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barré syndrome. Neuropsychiatr Dis Treat. 2018;14:1255-1260. doi:10.2147/NDT.S162896
  24. Khadilkar SV, Kamat S, Patel R. Nodo-paranodopathies: concepts, clinical implications, and management. Ann Indian Acad Neurol. 2022; 25(6):1001-1008. doi:10.4103/aian.aian_382_22
  25. Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021;397(10280):1214-1228. doi:10.1016/S0140-6736(21)00517-1
  26. Uncini A. Autoimmune nodo-paranodopathies 10 years later: clinical features, pathophysiology and treatment. J Peripher Nerv Syst. 2023;28 Suppl 3:S23-S35. doi:10.1111/jns.12569
  27. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome. Curr Treat Options Neurol. 2013;15(3):338-349. doi:10.1007/s11940-013-0231-z
  28. Susuki K, Yuki N, Schafer DP, et al. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol. 2012;233(1):534-542. doi:10.1016/j.expneurol.2011.11.039
  29. Sarejloo S, Khanzadeh S, Hosseini S, et al. Role of the neutrophil to lymphocyte ratio in Guillain Barré syndrome: a systematic review and meta-analysis. Mediators Inflamm. 2022;2022:3390831. doi:10.1155/2022/3390831